Solventum Corporation (SOLV) Free Cash Flow
Solventum Corporation (SOLV) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2022-12-31 | $1.43B |
| 2023-12-31 | $1.63B |
| 2024-12-31 | $805.00M |
| 2025-12-31 | -$10.00M |
How SOLV compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| AZTA | Azenta Inc. | $38.32M |
| KURA | Kura Oncology Inc. | -$70.70M |
| IDYA | IDEAYA Biosciences Inc. | -$73.47M |
| RGNX | REGENXBIO Inc. | -$126.38M |
| SMMT | Summit Therapeutics Inc. | -$142.25M |
These are five companies in the same sector as SOLV with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Solventum Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("SOLV", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SOLV | $91.53 | -0.09% | 1.01M |
| 3 | ||||
| 4 | ||||
| 5 |